Invizius is a biotech company developing H-Guard, a product designed to reduce inflammatory responses in dialysis and ICU patients undergoing continuous renal replacement therapy.

Laverock Therapeutics is a UK-based biotech company that develops a gene silencing platform for advanced human therapeutic applications, with a focus on regenerative medicine and immuno-oncology.